- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
California ultrasound law implements Cruise control
The California State Assembly has passed a bill that would restrict sales of ultrasound machines to medical professionals. The move follows public safety concerns raised by actor Tom Cruise's purchase of ultrasound equipment to perform exams on his pregnant fiancee in November 2005.
The California State Assembly has passed a bill that would restrict sales of ultrasound machines to medical professionals. The move follows public safety concerns raised by actor Tom Cruise's purchase of ultrasound equipment to perform exams on his pregnant fiancee in November 2005.
Citing fears that fans and other individuals may follow in Cruise's footsteps, Assemblyman Ted Lieu introduced legislation that would prohibit the sale or lease of ultrasound machines in California to anyone other than physicians, surgeons, or licensed medical facilities. The Assembly passed the bill in May. AB-2360 would make selling ultrasound machines to nonmedical professionals a misdemeanor punishable with jail time and a $1000 fine.
The American College of Radiology lauded the California Assembly for passing the bill and urged the state Senate to include a prohibition of sale to entrepreneurs who market keepsake ultrasound.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
